Type 1 diabetes isn't an overnight attack against the body's ability to make insulin. It can be a sustained campaign over years that relentlessly targets insulin-producing cells in the pancreas.

A UCLA research team has engineered a new type of immune cell that attacks atherosclerotic plaques—the fatty buildup inside artery walls that drives most heart attacks and strokes. These engineered ...

A UCLA research team has engineered a new type of immune cell that attacks atherosclerotic plaques — the fatty buildup inside artery walls that drives most heart attacks and strokes.

One of the long-standing puzzles in hypertension research concerns the role of the immune system in driving high blood ...

Encellin, Inc., a clinical-stage biotechnology company developing Encapsulated Cell Replacement Therapy (ENCRT), today announced a partnership with Breakthrough T1D, the leading global Type 1 Diabetes ...

Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi were awarded the 2025 Nobel Prize in Physiology or Medicine on Monday for their collective work in the discovery of specialized immune cells that roam ...

A combination blood stem cell and pancreatic islet cell transplant from an immunologically mismatched donor completely prevented or cured Type 1 diabetes in mice in a study by Stanford Medicine ...

Natural killer cells act as the immune system’s rapid-response team, but the stress of anxiety and insomnia may be quietly thinning their ranks. A study of young women in Saudi Arabia found that both ...

Despite having an overactive immune system, people with lupus may still struggle to fight bacterial infections. My team and I ...

One of the most stubborn puzzles in esophageal cancer research has just gained a striking new piece. Myeloid-derived ...